6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Original text

Rate this translation

Your feedback will be used to help improve Google Translate

Latest Press Releases

Time	Headline
20m ago	Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch
20m ago	Surface Transforms plc – in Administration, Sale of Business and Assets
20m ago	Guerbet: Changes to the Composition of Guerbet’s Board of Directors.
20m ago	RENAULT S.A. : disclosure of trading in own shares from May 15 to May 20, 2026
21m ago	Assystem: Combined General Meeting of 22 May 2026 - Voting Results and dividend for financial year 2025

About

242.00EUR+1.10 +0.46%

Closed • Updated at 16:55 GMT+00:00

Market Cap$53.17B

P/E Ratio30.16

Volume184.4K

Beta1.64

RSI50.68

Gross Margin71.14%

Health TechnologyPharmaceuticals: Major

Ucb S.a. — investor relations, events, news, and company updates on 6ix.

Latest News

UCB : Financial Reporting Document

UCB - Convening Notice to the General Meeting of the Shareholders 2026

Gen Z and Millennial Patients with Chronic Rheumatic Diseases Are Opening Up to Raise Awareness for Improved Care

UCB presents latest research and clinical advancement across leading epilepsy portfolio at International Epilepsy Congress

UCB's HS Summit United Patients and Experts to Drive Progress in Hidradenitis Suppurativa Awareness and Treatment

Community Chat

Ask AI